IRB Barcelona logo

News

Highlighting IRB Barcelona's impact on society

News

Scientific - Published in Nature Medicine
A role of colibactin-producing E. coli in carcinogenesis
Innovation
Iproteos, IRB Barcelona’s spin-off specialised in drugs to treat diseases of the central nervous system, is taken over by Accure Therapeutics
Institutional
Research centres in Catalonia have conducted 20,000 PCR tests to date
Scientific - Published in Nature Biotechnology
An open-access tool to accelerate drug discovery
Immunofluorescence of a mouse mammary gland duct (IRB Barcelona)
Scientific - Published in Science Advances
Identification of a determining factor in luminal cancer cells, that cause the greatest number of breast cancer cases
Tumour heterogeneity: cancer stem cells (green) and differentiated cells (in red). IRB Barcelona.
Scientific - Published in Cell Stem Cell
Biosynthetic capacity: the key to switch-off cancer stem cells
Institutional
IRB Barcelona in the fight against COVID-19
Kick-off meeting of the CALIPER consortium held in Thessaloniki (Greece) in January 2020.
Institutional
Target: Gender Equality. IRB Barcelona joins the CALIPER Project
Institutional
More than 5,000 applications received to participate in the NEUBIAS Academy’s online training courses on bioimage analysis

Media Mentions

Blog

Do you want to be informed?

Visit our blog.

IRB Blog